Efficacy of indacaterol/glycopyrronium versus salmeterol/fluticasone in current and ex-smokers: a pooled analysis of IGNITE trials

D. Halpin (Exeter, United Kingdom), C. Vogelmeier (Marburg, Germany), A. Mackay (London, United Kingdom), K. Mezzi (Basel, Switzerland), P. Goyal (Basel, Switzerland), P. Gupta (Hyderabad, India), K. Kostikas (Basel, Switzerland), J. Wedzicha (London, United Kingdom)

Source: International Congress 2018 – COPD management
Session: COPD management
Session type: Thematic Poster
Number: 4394
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Halpin (Exeter, United Kingdom), C. Vogelmeier (Marburg, Germany), A. Mackay (London, United Kingdom), K. Mezzi (Basel, Switzerland), P. Goyal (Basel, Switzerland), P. Gupta (Hyderabad, India), K. Kostikas (Basel, Switzerland), J. Wedzicha (London, United Kingdom). Efficacy of indacaterol/glycopyrronium versus salmeterol/fluticasone in current and ex-smokers: a pooled analysis of IGNITE trials. 4394

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: